Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
January 19, 2024 07:30 ET | Optimi Health Corp.
Optimi Health granted amendment to its Health Canada Controlled Drugs and Substances Licence.
Vantage Hemp Co. Sub
Vantage Hemp Co. Submits Drug Master File for CBD Isolate to the U.S. Food & Drug Administration
April 04, 2023 07:00 ET | Vantage Hemp
Greeley, Colorado, April 04, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces that it has submitted a Drug Master File (DMF) for its cannabidiol (CBD) Isolate to the...
Global Pharmaceutical API Manufacturing Market
Global $250+ Bn Pharmaceutical API Manufacturing (Chemical & Biological) Markets, 2016-2021, 2021-2026F, 2031F
April 13, 2022 04:58 ET | Research and Markets
Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Report 2022: By Therapy, By API, By Drug" report has been added to ResearchAndMarkets.com's offering. ...
Vantage Hemp Co.
Vantage Hemp Co. is in the Final Stages of its DMF Submissions
January 24, 2022 07:45 ET | Vantage Hemp
Greeley, Colorado, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”), an industry-leading manufacturer of pharmaceutical-grade CBD products, today announced that the...